EUROAPI’s Post

Check out our #LiveWithChaudhrey interview!

🎞 #LiveWithChaudhrey S05E193 with Abzena #18H11 Louise Duffy at CPHI Milan Oct 9th Day 2 It was lovely to catch up yesterday at #CPHIMilan with Louise who is Abzena's CTO and Chief Regulatory Officer to learn more about what they have been talking to visitors about this week in Milan, and some of the trends she has observed over the past 12momths, and what makes Abzena different to other CDMOs. There's still time to stop by the Abzena stand #18H11 to discuss your complex #biologic or #bioconjugate program with their experts during #CPHIMilan Take the opportunity to connect on your project-specific needs and an update on their expanded global #discovery, #development and #manufacturing capabilities. From #antibodies (#mAbs) to #recombinant #vaccines and #bioconjugates- including #ADCs, #radioconjugates, and #oligonucleotides, the team would like to share how #Abzena can assist in moving your program forward faster to its next milestone. Their team of experienced experts onsite will include: CCO, Joe Principe, Chief Technical and Quality Office, Louise Duffy, SVP & Scientific Leader, Dr. Petra Dieterich, DPhil, MBA, SVP of Global Marketing, Kimberly Burrell VP of Cell Line Development, Simon Keen, VP of Strategy, Gavin Murdoch Head of EU/ROW Sales, @Jonathan Cruikshank, VP of Business Development, Roger Bowie, VP of Business Development, Patrick Haddad, and VP of Business Development, Gildas Lavenant Can't make it today? You can meet the team 🤝 Next week at Festival of Biologics Basel 🤝 The week after at #AAPS #PharmSci360 #RSKCPHIMilan24 #RSKAbzena #CPHIWorldwide #DrugDevelopment #CDMO #CRO #Biopharma #Networking https://lnkd.in/ezaX-FYN

If you are at CPHI Riyadh this coming week, please join me for my talk on biosimilar production. Scaling this technology has its challenges. What comes to your mind? #chemicalengineering #biosimilars #biotechnology

We're here at the 35th International Symposium on ALS/MND... Our team are all set up at Booth 11 and ready for the influx of scientists, industry experts and members of the community at large who are about to flood through the doors of the Palais des Congres de Montreal. Don't forget to come say hello to us, we'd love to hear from you and possibly get the chance to shed more light about the possibilities that come with iPSCs in transforming ALS research and drug discovery. We will also be presenting a poster where we will be sharing characterization data we have done with our iPSC-derived motor neuron disease model for ALS as part of the ongoing effort to build a better human-relevant model of this disease: Poster: Characterization of human iPSC-derived motor neuron disease model for ALS drug discovery, presented by Adele Etienne Our team will be on Booth 11 so come and talk to us if you are interested in seeing some of this characterization data and hearing how our axoCells can support your ALS research needs. We are also running a 2-min survey where you as members of the ALS community, will be able to help shape the next generation of ALS models. We value your feedback and look forward to using it to develop more sophisticated and more human-relevant iPSC-fuelled models to support ALS drug discovery. To complete this short survey, click here: https://hubs.la/Q02-L3LN0 If you won't be at this event, you can also email us your questions at operations@axolbio.com. We'd be happy to help. See you at Booth 11! #ALSMontreal #humaniPSCs #drugdiscovery #collaboration

We're here at the 35th International Symposium on ALS/MND... Our team are all set up at Booth 11 and ready for the influx of scientists, industry experts and members of the community at large who are about to flood through the doors of the Palais des Congres de Montreal. Don't forget to come say hello to us, we'd love to hear from you and possibly get the chance to shed more light about the possibilities that come with iPSCs in transforming ALS research and drug discovery. We will also be presenting a poster where we will be sharing characterization data we have done with our iPSC-derived motor neuron disease model for ALS as part of the ongoing effort to build a better human-relevant model of this disease: Poster: Characterization of human iPSC-derived motor neuron disease model for ALS drug discovery, presented by Adele Etienne Our team will be on Booth 11 so come and talk to us if you are interested in seeing some of this characterization data and hearing how our axoCells can support your ALS research needs. We are also running a 2-min survey where you as members of the ALS community, will be able to help shape the next generation of ALS models. We value your feedback and look forward to using it to develop more sophisticated and more human-relevant iPSC-fuelled models to support ALS drug discovery. To complete this short survey, click here: https://hubs.la/Q02-L3WY0 If you won't be at this event, you can also email us your questions at operations@axolbio.com. We'd be happy to help. See you at Booth 11! #ALSMontreal #humaniPSCs #drugdiscovery #collaboration

Stop by the Aprecia Pharmaceuticals booth today to discuss how our 3DP Pharmaceutical Manufacturing Technology can help to solve your formulation challenges.

Count down: 7 days!

Second day at the 35th International Symposium on ALS/MND... Our team is set up at Booth 11 and ready for the influx of scientists, industry experts, and members of the community at large who are about to flood through the doors of the Palais des Congres de Montreal. Don't forget to come say hello to us, we'd love to hear from you and possibly get the chance to shed more light about the possibilities that come with iPSCs in transforming ALS research and drug discovery. We are presenting a poster where we will be sharing characterization data we have done with our iPSC-derived motor neuron disease model for ALS as part of the ongoing effort to build a better human-relevant model of this disease: Poster: Characterization of human iPSC-derived motor neuron disease model for ALS drug discovery, presented by Adele Etienne Our team will be on Booth 11 so come and talk to us if you are interested in seeing some of this characterization data and hearing how our axoCells can support your ALS research needs. We are also running a 2-min survey where you as members of the ALS community, will be able to help shape the next generation of ALS models. We value your feedback and look forward to using it to develop more sophisticated and more human-relevant iPSC-fuelled models to support ALS drug discovery. To complete this short survey, click here: https://hubs.la/Q02-RvvV0 If you won't be at this event, you can also email us your questions at operations@axolbio.com. We'd be happy to help. See you at Booth 11! Duncan Borthwick PhD #ALSMontreal #humaniPSCs #drugdiscovery #collaboration

An important milestone reached on our pathway towards Epidemic/Pandemic Preparedness. Looking forward to next steps to complete the entire Research Chain, from ideas to therapies in just few weeks. Yes, we can at Takis. Takis #geneticvaccines #epidemicpreparedness

Yesterday at TechTalk XL in the beautiful NecstGen facility in Leiden. Nice picture of the Dutch ATMP industry landscape. Great to see that the majority of these companies are customer of Progress - Experts in Life Sciences. Many thanks to the event team of Leiden Bio Science Park for organising this event with great speakers and very interesting presentations about developments in the ATMP field. Amongst others about new indications (e.g. CAR-T's moving to solid cancers) and developments in QC release assays, amongst others a rapid sterility assay. Since time needed for QC release has/will become the time limiting factor, faster release assays are highly needed in the ATMP field. #ATMP #WeAccelerateImprovement